Velzatinib (IDRX-42, GSK6042981)
StrateGIST 3
GSK · Phase 3 · Recruiting · Enrollment 450
| Arm | Reported safety |
|---|---|
| Velzatinib 300 mg | n/r |
| Sunitinib 50 mg 4/2 | n/r |
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Velzatinib (IDRX-42, GSK6042981)
GSK · Phase 3 · Recruiting · Enrollment 450
| Arm | Reported safety |
|---|---|
| Velzatinib 300 mg | n/r |
| Sunitinib 50 mg 4/2 | n/r |
A count stays a count. This page does not turn a count into a percent.